Xcout Intel
Endogena Therapeutics Inc. competitors & alternatives
The 12 closest competitors and alternatives to Endogena Therapeutics Inc. among biotechnology companies — ranked by similarity to what Endogena Therapeutics Inc. actually does, not by market-cap band.
Subscribe to see Endogena Therapeutics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Endogena Therapeutics Inc.
Endogena Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Zürich, Switzerland, that discovers and develops first-in-class endogenous regenerative medicines to repair tissues.
Endogena Therapeutics Inc. at a glance
Endogena Therapeutics Inc. is a biotechnology company headquartered in Switzerland. It has raised at least $37M across the 2 funding rounds on record. Its most recent funding round, Series A-1, raised $29M in November 2021. Xcout tracks 10 named people at Endogena Therapeutics Inc., including Etienne Binant (Interim CEO).
Endogena Therapeutics Inc. leadership
- Etienne BinantInterim CEO
- Susanne RaabChief Development Officer
- Mike TanjiChairman
- Gisbert SchneiderCo-Founder / ETH Zürich
- Matthias StegerFounder
- Michelle WidmannHead of Clinical Operations US
4 more named people on record for Endogena Therapeutics Inc., with roles, board committees and tenure — see the full roster →
Endogena Therapeutics Inc. funding rounds
At least $37M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A-1 | $29M | 3 named | |
| SEC Form D filing | $8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Endogena Therapeutics Inc. competitors
Ranked by semantic similarity — how close each company is to Endogena Therapeutics Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Ultimate Medicine AG is a Swiss preclinical biotechnology company headquartered in Zürich, focused on maximizing the healthspan of patients with Alzheimer's disease and other dementias by targeting novel toxic metabolites.
Biotech
Aspect Biosystems develops bioengineered cellular medicines and implantable tissue therapeutics using a proprietary bioprinting platform that integrates AI, computational design, and advanced biomaterials. The company serves the biotechnology and pharmaceutical industries by creating treatments to replace, repair, or supplement biological functions for metabolic and endocrine diseases.
Similar biotechnology company
GlycoEra AG is a biotechnology company focused on advancing glycan-mediated therapy through game-changing protein engineering. Headquartered in Wädenswil, Switzerland, the company also maintains an office in Newton, Massachusetts.
Biotech / Healthcare
Cyclana Bio is a biotechnology company headquartered in Cambridge, United Kingdom, pioneering tissue-level approaches to advance drug discovery and uncover mechanisms in women's health.
Biotech
Envisagenics, Inc. is an active biotechnology research company co-founded by Dr. Maria Luisa Pineda. Headquartered in New York City, the company applies advanced computational platforms and data analytics to discover novel therapeutics and targets for complex diseases.
Biotechnology / Life Science
Engitix is a biotechnology company that utilizes a proprietary platform based on human Extracellular Matrix (ECM) scaffolds to model and study disease biology. The company develops discovery-stage therapeutics targeting fibrosis, inflammation, and solid tumors, and forms partnerships with pharmaceutical and biotech organizations.
Similar biotechnology company
Paean Holdings, Inc. (operating as PAEAN Biotechnology) develops mitochondria-based therapeutics designed to treat rare diseases, inflammatory conditions, cancer, and central nervous system disorders. The company utilizes proprietary platforms including mitochondrial transplantation, modified mitochondria for targeted delivery, and mitochondria-augmented cell therapy to address critical medical needs and overcome cellular metabolic limitations.
Biotech
Senda Biosciences is a biotechnology company focused on harnessing nature to program novel medicines, headquartered in Cambridge, Massachusetts.
Biotech
NGM Biopharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in South San Francisco, California, focused on discovering and developing transformative therapeutics.
Similar biotechnology company
BIND Therapeutics, Inc. is a clinical-stage nanomedicine company headquartered in Cambridge, Massachusetts. The company specializes in developing targeted and programmable therapeutics using its proprietary platform to treat various diseases.
Biotech
Juvenescence Ltd is a life sciences and clinical-stage AI-enabled biotech company headquartered in Dublin, Ireland, dedicated to extending healthy lifespan through novel medicines.
Pharmaceuticals and Biotechnology
Anagenex is a biotechnology company that uses high-throughput experimentation, functional screening, and machine learning to discover small-molecule drug candidates. It focuses on challenging drug targets and works with biopharmaceutical companies as well as developing its own therapeutic programs.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Endogena Therapeutics Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Endogena Therapeutics Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →